$13.00
-1.66-11.32%
Últ. Act.: Oct 6, 4:29 PM
$13.00
-1.66-11.32%
Arcturus Therapeutics (ARCT) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-1.03 | $-1.04 | $-0.82 | $-0.98 |
| Actual | $-0.84 | $-0.95 | $-1.03 | $-0.49 |
| Surprise | +18.4% | +8.65% | -25.6% | +50.0% |
| Revenue | ||||
| Estimate | $3.0M | $7.1M | $14.3M | $14.2M |
| Actual | $3.0M | $2.1M | $7.2M | $17.2M |
| Surprise | -1.38% | -70.8% | -49.8% | +21.0% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.66 | $-0.92 | $-0.89 | $-0.91 |
| Revenue | ||||
| Consensus | $8.1M | $5.7M | — | — |
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $-0.84 | $-1.03 | 18.4 % |
| Q1 | May 7, 2026 | $-0.95 | $-1.04 | 8.65 % |
| Q4 | Mar 3, 2026 | $-1.03 | $-0.82 | -25.6 % |
| Q3 | Nov 10, 2025 | $-0.49 | $-0.98 | 50.0 % |
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $2.96M | $3.00M | -1.38 % |
| Q1 | May 7, 2026 | $2.06M | $7.07M | -70.8 % |
| Q4 | Mar 3, 2026 | $7.20M | $14.34M | -49.8 % |
| Q3 | Nov 10, 2025 | $17.15M | $14.18M | 21.0 % |